These mice are transgenic for the mutated form of the rat ortholog of the human epidermal growth factor receptor 2 (Her2) oncogene under the transcriptional control of the mouse mammary tumor virus promoter and develop mammary carcinomas with well-defined progression, which resembles that of human breast tumors in many aspects [37,38,39]. The gene discussed is ERBB2; the disease is breast neoplasm.